Baxter v. Spectranetics
This article was originally published in The Gray Sheet
Executive Summary
Patent infringement suit is filed by Baxter in Delaware district court alleging that Spectranetics' CVX-300 excimer laser system infringes three patents licensed by Baxter from Lasersight (patent number 4,784,135), Acculase (4,891,818), and the U.S. Department of Energy/Argonne National Laboratory (4,686,979). The patents cover cardiovascular and vascular uses of excimer laser technology. Spectranetics' CVX-300 is approved for laser angioplasty in coronary arteries. The company also is planning trials in October to use the system to treat in-stent restenosis